| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; loading ...; fig 3d
- western blot; human; loading ...; fig 4b
| Kreger B, Johansen E, Cerione R, Antonyak M. The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance. Cancers (Basel). 2016;8: pubmed |
- western blot; human; loading ...; fig 1c
| Schafer C, Göder A, Beyer M, Kiweler N, Mahendrarajah N, Rauch A, et al. Class I histone deacetylases regulate p53/NF-?B crosstalk in cancer cells. Cell Signal. 2017;29:218-225 pubmed publisher |
- immunocytochemistry; human; 1:300; loading ...; fig 3
| Unruhe Knauf B, Knauer S. Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization. Methods Mol Biol. 2017;1510:47-59 pubmed |
- western blot; human; 1:1000; fig 3
| Iimori M, Watanabe S, Kiyonari S, Matsuoka K, Sakasai R, Saeki H, et al. Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability. Nat Commun. 2016;7:11117 pubmed publisher |
| Stahl P, Kollenda S, Sager J, Schmidt L, Schroer M, Stauber R, et al. Tuning Nanobodies' Bioactivity: Coupling to Ultrasmall Gold Nanoparticles Allows the Intracellular Interference with Survivin. Small. 2023;19:e2300871 pubmed publisher |
| Dyshlovoy S, Shubina L, Makarieva T, Guzii A, Hauschild J, Strewinsky N, et al. New Guanidine Alkaloids Batzelladines O and P from the Marine Sponge Monanchora pulchra Induce Apoptosis and Autophagy in Prostate Cancer Cells. Mar Drugs. 2022;20: pubmed publisher |
| Vay C, Babaei S, Safi S, Dizdar L, Rehders A, Haeberle L, et al. Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2022;14: pubmed publisher |
| da Costa Lopes J, Falc xe3 o L, Martins Filho A, Carvalho M, Mendes C, Ol xed mpio F, et al. Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis. Viruses. 2022;14: pubmed publisher |
| Mackay R, Weinberger P, Copland J, Mahdavian E, Xu Q. YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site. Mol Cancer Ther. 2022;21:925-935 pubmed publisher |
| Rodrigues de Sousa J, Magno Falc xe3 o L, Virgolino G, Santos Cruz M, Teixeira V, Leila de Souza Aar xe3 o T, et al. Different cell death mechanisms are involved in leprosy pathogenesis. Microb Pathog. 2022;166:105511 pubmed publisher |
| Almeida A, Soares de Oliveira J, Drpic D, Cheeseman L, Damas J, Lewin H, et al. Augmin-dependent microtubule self-organization drives kinetochore fiber maturation in mammals. Cell Rep. 2022;39:110610 pubmed publisher |
| Vay C, Schlünder P, Dizdar L, Esposito I, Ghadimi M, Knoefel W, et al. Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment. J Cancer Res Clin Oncol. 2022;148:633-645 pubmed publisher |
| Arista Romero M, Cascante A, Fornaguera C, Borros S. Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy. Pharmaceutics. 2021;13: pubmed publisher |
| Di Vincenzo S, Sangiorgi C, Ferraro M, Buscetta M, Cipollina C, Pace E. Cigarette smoke extract reduces FOXO3a promoting tumor progression and cell migration in lung cancer. Toxicology. 2021;454:152751 pubmed publisher |
| Oliveira A, Zerillo L, Cruz L, Schomann T, Chan A, de Carvalho T, et al. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer. Mater Sci Eng C Mater Biol Appl. 2021;120:111678 pubmed publisher |
| Ferguson Bennit H, Gonda A, Kabagwira J, Oppegard L, Chi D, Licero Campbell J, et al. Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes. Int J Mol Sci. 2021;22: pubmed publisher |
| Abdo W, Elmadawy M, Abdelhiee E, Abdel Kareem M, Farag A, Aboubakr M, et al. Protective effect of thymoquinone against lung intoxication induced by malathion inhalation. Sci Rep. 2021;11:2498 pubmed publisher |
| Murillo Pineda M, Valente L, Dumont M, Mata J, Fachinetti D, Jansen L. Induction of spontaneous human neocentromere formation and long-term maturation. J Cell Biol. 2021;220: pubmed publisher |
| Tsunematsu T, Arakaki R, Kawai H, Ruppert J, Tsuneyama K, Ishimaru N, et al. APC/CCdh1 is required for the termination of chromosomal passenger complex activity upon mitotic exit. J Cell Sci. 2020;133: pubmed publisher |
| Nourreddine S, Lavoie G, Paradis J, Ben El Kadhi K, Méant A, Aubert L, et al. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay. Cell Rep. 2020;31:107660 pubmed publisher |
| Dyshlovoy S, Pelageev D, Hauschild J, Sabutskii Y, Khmelevskaya E, Krisp C, et al. Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer. Mar Drugs. 2020;18: pubmed publisher |
| Erdogan S, Türkekul K. Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation. J Food Biochem. 2020;44:e13253 pubmed publisher |
| Thamm D, Joseph J, Rose B, Meuten T, Weishaar K. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma. BMC Vet Res. 2020;16:97 pubmed publisher |
| Brown M, Zhang W, Yan D, Kenath R, Le L, Wang H, et al. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLoS ONE. 2020;15:e0226917 pubmed publisher |
| Liang C, Zhang Z, Chen Q, Yan H, Zhang M, Zhou L, et al. Centromere-localized Aurora B kinase is required for the fidelity of chromosome segregation. J Cell Biol. 2020;219: pubmed publisher |
| Mirshahidi S, De Necochea Campion R, Moretta A, Williams N, Reeves M, Otoukesh S, et al. Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro. Cancer Invest. 2020;38:23-36 pubmed publisher |
| Zhou J, Liu S, Wang Y, Dai W, Zou H, Wang S, et al. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Mol Cancer. 2019;18:159 pubmed publisher |
| Abad M, Ruppert J, Buzuk L, Wear M, Zou J, Webb K, et al. Borealin-nucleosome interaction secures chromosome association of the chromosomal passenger complex. J Cell Biol. 2019;218:3912-3925 pubmed publisher |
| Ong S, Saeki K, Kok M, Nakagawa T, Nishimura R. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells. J Vet Med Sci. 2019;81:1182-1190 pubmed publisher |
| Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, et al. Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series. Cancer Sci. 2019;110:2386-2395 pubmed publisher |
| Latifkar A, Ling L, Hingorani A, Johansen E, Clement A, Zhang X, et al. Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell. 2019;49:393-408.e7 pubmed publisher |
| Zuckerman L, Frames W, Elsissy J, Shields T, De Necochea Campion R, Mirshahidi H, et al. The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells. Eur Rev Med Pharmacol Sci. 2019;23:2681-2690 pubmed publisher |
| Zito P, Labbozzetta M, Notarbartolo M, Sajeva M, Poma P. Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells. PLoS ONE. 2019;14:e0214594 pubmed publisher |
| Ketteler J, Panic A, Reis H, Wittka A, Maier P, Herskind C, et al. Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1. J Clin Med. 2019;8: pubmed publisher |
| Lionetti M, Mutti F, Soldati E, Fumagalli M, Coccè V, Colombo G, et al. Sulforaphane Cannot Protect Human Fibroblasts From Repeated, Short and Sublethal Treatments with Hydrogen Peroxide. Int J Environ Res Public Health. 2019;16: pubmed publisher |
| Mega Tiber P, Kocyigit Sevinc S, Kilinc O, Orun O. Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562. Gene. 2019;692:217-222 pubmed publisher |
| Liu T, Liu J, Chen Q, Jin S, Mi S, Shao W, et al. Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma. Oncol Lett. 2019;17:2040-2046 pubmed publisher |
| Ferraro M, Di Vincenzo S, Dino P, Bucchieri S, Cipollina C, Gjomarkaj M, et al. Budesonide, Aclidinium and Formoterol in combination limit inflammaging processes in bronchial epithelial cells exposed to cigarette smoke. Exp Gerontol. 2019;118:78-87 pubmed publisher |
| Kim W, Ryu J, Kim J. CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells. Int J Mol Sci. 2019;20: pubmed publisher |
| Hwang J, Park J, Kim M, Kim W, Ha K, Choi B, et al. Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model. Cancer Lett. 2018;443:25-33 pubmed publisher |
| Gonda A, Kabagwira J, Senthil G, Ferguson Bennit H, Neidigh J, Khan S, et al. Exosomal survivin facilitates vesicle internalization. Oncotarget. 2018;9:34919-34934 pubmed publisher |
| Giuliani A, Cirilli I, Prattichizzo F, Mensà E, Fulgenzi G, Sabbatinelli J, et al. The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells. Aging (Albany NY). 2018;10:2855-2873 pubmed publisher |
| Humphry N, Wheatley S. Survivin inhibits excessive autophagy in cancer cells but does so independently of its interaction with LC3. Biol Open. 2018;7: pubmed publisher |
| Wang T, Huang J, Vue M, Alavian M, Goel H, Altieri D, et al. αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin. Mol Cancer Res. 2019;17:398-408 pubmed publisher |
| Troiano G, Guida A, Aquino G, Botti G, Losito N, Papagerakis S, et al. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19: pubmed publisher |
| Gock M, Mullins C, Harnack C, Prall F, Ramer R, Göder A, et al. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World J Gastroenterol. 2018;24:3749-3759 pubmed publisher |
| Lee H, Carmena M, Liskovykh M, Peat E, Kim J, Oshimura M, et al. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy. Cancer Res. 2018;78:6282-6296 pubmed publisher |
| Erdogan S, Türkekul K, Dibirdik I, Doganlar O, Doganlar Z, Bilir A, et al. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed Pharmacother. 2018;107:793-805 pubmed publisher |
| Novais Cruz M, Alba Abad M, van IJcken W, Galjart N, Jeyaprakash A, Maiato H, et al. Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription. elife. 2018;7: pubmed publisher |
| Rauch A, Carlstedt A, Emmerich C, Mustafa A, Göder A, Knauer S, et al. Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells. Oncotarget. 2018;9:27835-27850 pubmed publisher |
| Kiweler N, Brill B, Wirth M, Breuksch I, Laguna T, Dietrich C, et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch Toxicol. 2018;92:2227-2243 pubmed publisher |
| Drpic D, Almeida A, Aguiar P, Renda F, Damas J, Lewin H, et al. Chromosome Segregation Is Biased by Kinetochore Size. Curr Biol. 2018;28:1344-1356.e5 pubmed publisher |
| Dizdar L, Jünemann L, Werner T, Verde P, Baldus S, Stoecklein N, et al. Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer. Oncol Lett. 2018;15:3779-3789 pubmed publisher |
| Wei Q, Li J, Tang F, Yin Y, Zhao Y, Yao Q. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents. Eur J Med Chem. 2018;144:504-516 pubmed publisher |
| Tastekin E, Caloglu V, Durankus N, Sut N, Turkkan G, Can N, et al. Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time. Arch Med Sci. 2017;13:1467-1473 pubmed publisher |
| Liang C, Chen Q, Yi Q, Zhang M, Yan H, Zhang B, et al. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion. EMBO Rep. 2018;19:43-56 pubmed publisher |
| Dizdar L, Tomczak M, Werner T, Safi S, Riemer J, Verde P, et al. Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas. Oncol Lett. 2017;14:6847-6856 pubmed publisher |
| Zhang J, Jin Y, Pan J. Inhibitory effect of the anthelmintic drug pyrvinium pamoate on T315I BCR?ABL?positive CML cells. Mol Med Rep. 2017;16:9217-9223 pubmed publisher |
| Khan S, Simpson J, Lynch J, Turay D, Mirshahidi S, Gonda A, et al. Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS ONE. 2017;12:e0183122 pubmed publisher |
| Taglieri L, Rubinacci G, Giuffrida A, Carradori S, Scarpa S. The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells. Invest New Drugs. 2018;36:28-35 pubmed publisher |
| Ong S, Saeki K, Kok M, Tanaka Y, Choisunirachon N, Yoshitake R, et al. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model. Res Vet Sci. 2017;113:130-135 pubmed publisher |
| Taglieri L, DE Iuliis F, Giuffrida A, Giantulli S, Silvestri I, Scarpa S. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncol Lett. 2017;14:3832-3838 pubmed publisher |
| Werner T, Dizdar L, Nolten I, Riemer J, Mersch S, Schütte S, et al. Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma. Sci Rep. 2017;7:11383 pubmed publisher |
| Craparo E, Ferraro M, Pace E, Bondi M, Giammona G, Cavallaro G. Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects. Nanomaterials (Basel). 2017;7: pubmed publisher |
| Bradford E, Ryu S, Singh A, Lee G, Goretsky T, Sinh P, et al. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease. J Immunol. 2017;199:1886-1897 pubmed publisher |
| Wang H, Jin S, Lu H, Mi S, Shao W, Zuo X, et al. Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics. Oncol Lett. 2017;14:1011-1016 pubmed publisher |
| Magadum A, Ding Y, He L, Kim T, Vasudevarao M, Long Q, et al. Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair. Cell Res. 2017;27:1002-1019 pubmed publisher |
| Scheer A, Knauer S, Verhaegh R. Survivin expression pattern in the intestine of normoxic and ischemic rats. BMC Gastroenterol. 2017;17:76 pubmed publisher |
| Tung J, Tew L, Hsu Y, Khung Y. A novel 4-arm DNA/RNA Nanoconstruct triggering Rapid Apoptosis of Triple Negative Breast Cancer Cells within 24?hours. Sci Rep. 2017;7:793 pubmed publisher |
| Liu S, Shi L, Yang X, Ye D, Wang T, Dong C, et al. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. Cell Cycle. 2017;16:894-902 pubmed publisher |
| Chen B, Wei W, Ma L, Yang B, Gill R, Chua M, et al. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology. 2017;152:2022-2036 pubmed publisher |
| Kim W, Cheon M, Kim J. Mitochondrial CCAR2/DBC1 is required for cell survival against rotenone-induced mitochondrial stress. Biochem Biophys Res Commun. 2017;485:782-789 pubmed publisher |
| Dheekollu J, Malecka K, Wiedmer A, Delecluse H, Chiang A, Altieri D, et al. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget. 2017;8:7248-7264 pubmed publisher |
| Nonagase Y, Yonesaka K, Kawakami H, Watanabe S, Haratani K, Takahama T, et al. Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget. 2016;7:84860-84871 pubmed publisher |
| Redli P, Gasic I, Meraldi P, Nigg E, Santamaria A. The Ska complex promotes Aurora B activity to ensure chromosome biorientation. J Cell Biol. 2016;215:77-93 pubmed |
| Lettini G, Sisinni L, Condelli V, Matassa D, Simeon V, Maddalena F, et al. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Cell Death Differ. 2016;23:1792-1803 pubmed publisher |
| Makii C, Oda K, Ikeda Y, Sone K, Hasegawa K, Uehara Y, et al. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. Oncotarget. 2016;7:75328-75338 pubmed publisher |
| Genshaft A, Li S, Gallant C, Darmanis S, Prakadan S, Ziegler C, et al. Multiplexed, targeted profiling of single-cell proteomes and transcriptomes in a single reaction. Genome Biol. 2016;17:188 pubmed publisher |
| Varughese R, Torp S. Survivin and gliomas: A literature review. Oncol Lett. 2016;12:1679-1686 pubmed |
| Tastekin E, Caloglu V, Puyan F, Tokuc B, Caloglu M, Yalta T, et al. Prognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma. Turk Neurosurg. 2016;26:484-90 pubmed publisher |
| Alzoubi S, Brody L, Rahman S, Mahul Mellier A, Mercado N, Ito K, et al. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget. 2016;7:44505-44521 pubmed publisher |
| Pace E, Di Vincenzo S, Ferraro M, Bruno A, Dino P, Bonsignore M, et al. Carbocysteine counteracts the effects of cigarette smoke on cell growth and on the SIRT1/FoxO3 axis in bronchial epithelial cells. Exp Gerontol. 2016;81:119-28 pubmed publisher |
| Qi G, Kudo Y, Tang B, Liu T, Jin S, Liu J, et al. PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer. Oncotarget. 2016;7:18812-24 pubmed publisher |
| Wu X, Tang W, Marquez R, Li K, Highfill C, He F, et al. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Oncotarget. 2016;7:11708-23 pubmed publisher |
| Werner T, Tamkan Ölcek Y, Dizdar L, Riemer J, Wolf A, Cupisti K, et al. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma. Br J Cancer. 2016;114:427-34 pubmed publisher |
| Lotti R, Palazzo E, Petrachi T, Dallaglio K, Saltari A, Truzzi F, et al. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo. Int J Mol Sci. 2016;17: pubmed publisher |
| Christenson J, Denny E, Kane S. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib. Oncotarget. 2015;6:33134-45 pubmed publisher |
| Fukuda T, Wada Hiraike O, Oda K, Tanikawa M, Makii C, Inaba K, et al. Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett. 2015;589:2274-81 pubmed publisher |
| Labarrade F, Bergeron L, Serre C, Lebleu A, Busuttil V, Botto J, et al. Modulating the expression of survivin and other basal epidermal proteins protects human skin from UVB damage and oxidative stress. J Cosmet Dermatol. 2015;14:191-203 pubmed publisher |
| Papini D, Langemeyer L, Abad M, Kerr A, Samejima I, Eyers P, et al. TD-60 links RalA GTPase function to the CPC in mitosis. Nat Commun. 2015;6:7678 pubmed publisher |
| Yamazaki H, Takagi S, Hosoya K, Okumura M. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells. Vet J. 2015;205:375-80 pubmed publisher |
| Locke F, Menges M, Veerapathran A, Coppola D, Gabrilovich D, Anasetti C. Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. J Immunother Cancer. 2015;3:20 pubmed publisher |
| Valenzuela M, Ferguson Bennit H, Gonda A, Diaz Osterman C, Hibma A, Khan S, et al. Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP). Cancer Microenviron. 2015;8:65-73 pubmed publisher |
| Bongiovanni L, D Andrea A, Porcellato I, Ciccarelli A, Malatesta D, Romanucci M, et al. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression. Vet Dermatol. 2015;26:270-e59 pubmed publisher |
| Sadowski S, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, et al. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Oncotarget. 2015;6:18038-49 pubmed |
| Mehta A, Zhang L, Boufraqech M, Liu Chittenden Y, Zhang Y, Patel D, et al. Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer. Clin Cancer Res. 2015;21:4123-32 pubmed publisher |
| Zhang L, Zhang Y, Mehta A, Boufraqech M, Davis S, Wang J, et al. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. Oncotarget. 2015;6:9073-85 pubmed |
| Lan L, Appelman C, Smith A, Yu J, Larsen S, Marquez R, et al. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Mol Oncol. 2015;9:1406-20 pubmed publisher |
| Sulaiman M, Chu Z, Blanco V, Vallabhapurapu S, Franco R, Qi X. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Mol Cancer. 2015;14:78 pubmed publisher |
| Meidhof S, Brabletz S, Lehmann W, Preca B, Mock K, Ruh M, et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med. 2015;7:831-47 pubmed publisher |
| Bonora M, Wieckowsk M, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 2015;34:1608 pubmed publisher |
| Yamazaki H, Takagi S, Hosoya K, Okumura M. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models. Res Vet Sci. 2015;99:137-44 pubmed publisher |
| Wu X, Yamamoto H, Nakanishi H, Yamamoto Y, Inoue A, Tei M, et al. Innovative delivery of siRNA to solid tumors by super carbonate apatite. PLoS ONE. 2015;10:e0116022 pubmed publisher |
| Yi X, Han T, Li Y, Long X, Li W. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. Mol Med Rep. 2015;12:601-8 pubmed publisher |
| Lu H, Cao X, Chen Q, Chen L, Chen L, Gan M. The expression and role of MEKK3 in renal clear cell carcinoma. Anat Rec (Hoboken). 2015;298:727-34 pubmed publisher |
| Vogt N, Abramov D, Koch K, Masque Soler N, Szczepanowski M, Klapper W. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leuk Lymphoma. 2015;56:2134-40 pubmed publisher |
| Artesi M, Kroonen J, Bredel M, Nguyen Khac M, Deprez M, Schoysman L, et al. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro Oncol. 2015;17:392-406 pubmed publisher |
| Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S, et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer. 2015;136:1308-20 pubmed publisher |
| Ramírez Labrada A, López Royuela N, Jarauta V, Galán Malo P, Azaceta G, Palomera L, et al. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl Oncol. 2015;17:121-32 pubmed publisher |
| Kapinas K, Kim H, Mandeville M, Martin Buley L, Croce C, Lian J, et al. microRNA-mediated survivin control of pluripotency. J Cell Physiol. 2015;230:63-70 pubmed publisher |
| Neef R, Preisinger C, Sutcliffe J, Kopajtich R, Nigg E, Mayer T, et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J Cell Biol. 2003;162:863-75 pubmed |
